The burgeoning popularity of semaglutide , initially for metabolic conditions, is creating significant attention within the UK , prompting a notable shift in hormone trends. Access these medications remains a complex situation , with NHS approval currently limited and specialist practices offering prescriptions at a substantial price. Concerns are